Blockade of a chemokine, CCL2, reduces chronic colitis-associated carcinogenesis in mice

Cancer Research

Volumn 69, Issue 19, 2009, Pages 7884-7892

  Popivanova, Boryana Konstantinova ^a   Kostadinova, Feodora Ivanova ^a   Furuichi, Kengo ^a   Shamekh, Mohamed M ^a   Kondo, Toshikazu ^b   Wada, Takashi ^a   Egashira, Kensuke ^c   Mukaida, Naofumi ^a  

^a KANAZAWA UNIVERSITY   (Japan)

^b WAKAYAMA MEDICAL UNIVERSITY   (Japan)

^c KYUSHU UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOOXYGENASE 2; MONOCYTE CHEMOTACTIC PROTEIN 1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL INFILTRATION; COLON CANCER; COLON CARCINOGENESIS; COLON TUMOR; CONTROLLED STUDY; DISEASE COURSE; FEMALE; MACROPHAGE; MALE; MOUSE; NEOVASCULARIZATION (PATHOLOGY); NONHUMAN; OBSERVATIONAL STUDY; PRIORITY JOURNAL; PROTEIN DEFICIENCY; PROTEIN EXPRESSION; TUMOR VOLUME; ULCERATIVE COLITIS;

ANIMALS; AZOXYMETHANE; CHEMOKINE CCL2; COLITIS, ULCERATIVE; COLONIC NEOPLASMS; CYCLOOXYGENASE 2; DEXTRAN SULFATE; FEMALE; HUMANS; MALE; MICE; MICE, INBRED BALB C; MICE, TRANSGENIC; ORGANOMETALLIC COMPOUNDS; RECEPTORS, CCR2; RNA, MESSENGER;

EID: 70350227255     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-09-1451     Document Type: Article

References (51)

1. Fiocchi C. Inflammatorybowel disease: etiology and pathogenesis. Gastroenterology1998;115 :182-205.
2. Ullman T, Croog V, Harpaz N, Sachar D, Itzkowitz S. Progression of flat low-grade dysplasia to advanced neoplasia in patients with ulcerative colitis. Gastroenterology200 3;125:1311-1319
3. Balkwill F, Mantovani A. Inflammation and cancer: back to Virchow? Lancet 2001;357:539-545
4. Okayasu I, Hatakeyama S, Yamada M, Ohkusa T, Inagaki Y, Nakaya R. A novel method in the induction of reliable experimental acute and chronic ulcerative colitis in mice. Gastroenterology199 0;98:694-702.
5. Okayasu I, Yamada M, Mikami T, Yoshida T, Kanno J, Ohkusa T. Dysplasia and carcinoma development in a repeated dextran sulfate sodium-induced colitis model. J Gastroenterol Hepatol 2002;17:1078-1083 (Pubitemid 35013962)
6. Okayasu I, Ohkusa T, Kajiura K, Kanno J, Sakamoto S. Promotion of colorectal neoplasia in experimental murine ulcerative colitis. Gut 1996;39:87-92. (Pubitemid 26239112)
7. Greten FR, Eckmann L, Greten TF, et al. IKKh links inflammation and tumorigenesis in a mouse model of colitis-associated cancer. Cell 2004;118:285-296 (Pubitemid 39061110)
8. Reimund JM, Wittersheim C, Dumont S, et al. Mucosal inflammatorycy tokine production byintestinal biopsies in patients with ulcerative colitis and Crohn's disease. J Clin Immunol 1996;16:144-150 (Pubitemid 26166392)
9. Wang H, Czura CJ, TraceyK J. Tumor necrosis factor. In: Thomson AW, Lotze MT, editors. The Cytokine Handbook. 4th ed. London: Elsevier Science Ltd.; 2003. p. 837-860
10. Popivanova BK, Kitamura K, Wu Y, et al. Blocking TNF-α in mice reduces colorectal carcinogenesis associated with chronic colitis. J Clin Invest 2008;118: 560-570 (Pubitemid 351206546)
11. Mazzucchelli L, Hauser C, Zgraggen K, et al. Differential in situ expression of the genes encoding the chemokines MCP-1 and RANTES in human inflammatorybowel disease. J Pathol 1996;178:201-206 (Pubitemid 26057973)
12. Reinecker C, Loh EY, Ringler DJ, Mehta A, Rombeau JL, MacDermott RP. Monocyte-chemoattractant protein 1 gene expression in intestinal epithelial cells and inflammatorybowel disease mucosa. Gastroenterology 1995;108:40-50.
13. Uguccioni M, Gionchetti P, Robbiani DF, et al. Increased expression of IP-10, IL-8, MCP-1 and MCP-3 in ulcerative colitis. Am J Pathol 1999;155:331-336 (Pubitemid 29370382)
14. Matsushima K, Larsen CG, DuBois GC, Oppenheim JJ. Purification and characterization of a novel monocyte chemotactic and activating factor produced bya human myelomonocytic cell line. J Exp Med 1989;169:1485-1490 (Pubitemid 19104979)
15. Zhang Y, Rollins BJ. A dominant negative inhibitor indicates that monocyte chemoattractant protein 1 functions as a dimer. Mol Cell Biol 1995;15:4851-4855
16. Yang X, Lu P, Ishida Y, Kuziel WA, Fujii C, Mukaida N. Attenuated liver tumor formation in the absence of CCR2 with a concomitant reduction in the accumulation of hepatic stellate cells, macrophages and neovascularization. Int J Cancer 2006;118:335-345 (Pubitemid 41779072)
17. Wu Y, Li Y-Y, Matsushima K, Baba T, Mukaida N. CCL3-5 axis regulates intratumoral accumulation of leukocytes and fibroblasts and promotes angiogenesis in murine lung metastasis process. J Immunol 2008;181: 6384-6393
18. Takahashi M, Wakabayashi K. Gene mutations and altered gene expression in azoxymethane-induced colon carcinogenesis in rodents. Cancer Sci 2004;95: 475-480 (Pubitemid 38832695)
19. Wong LM, Myers SJ, Tsou CL, Gosling J, Arai H, Charo IF. Organization and differential expression of the human monocyte chemoattractant protein 1 receptor gene. J Biol Chem 1997;272:1038-1045
20. Dwinell MB, Eckmann L, Leopard JD, Varki NM, Kagnoff MF. Chemokine receptor expression byhum an intestinal epithelial cells. Gastroenterology199 9;117: 359-367
21. Charo IF, Myers SJ, Herman A, Franci C, Connolly AJ, Coughlin SR. Molecular cloning and functional expression of two monocyte chemoattractant protein 1 receptors reveals alternative splicing of the carboxyl-terminal tails. Proc Natl Acad Sci U S A 1994;91:2752-2756 (Pubitemid 24139426)
22. Wada T, Yokoyama H, Furuichi K, et al. Intervention of crescentic glomerulonephritis byanti bodies to monocyte chemotactic and activating factor (MCAF/ MCP-1). FASEB J 1996;10:1418-1425 (Pubitemid 126785081)
23. Kimura H, Kasahara Y, Kurosu K, et al. Alleviation of monocrotaline-induced pulmonaryhy pertension by antibodies to monocyte chemotactic and activating factor/monocyte chemoattractant protein-1. Lab Invest 1998;78:571-578 (Pubitemid 28246981)
24. Moore BB, Paine R III, Christensen PJ, et al. Protection from pulmonaryfibrosis in the absence of CCR2 signaling. J Immunol 2001;167:4368-4377
25. -/- mice reveals a role for chemokines in the initiation of atherosclerosis. Nature 1998;394:894-897
26. Izikson L, Klein RS, Charo IF, Weiner HL, Luster AD. Resistance to experimental autoimmune encephalomyelitis in mice lacking the CC chemokine receptor (CCR) 2. J Exp Med 2000;192:1075-1080 (Pubitemid 30765700)
27. Shahrara S, Proudfoot AEI, Park CC, et al. Inhibition of monocyte chemoattractant protein-1 ameliorates rat adjuvant-induced arthritis. J Immunol 2008; 180:3447-3456
28. Guijarro LG, Mate J, Gisbert JP, et al. N-acetyl-Lcysteine combined with mesalamine in the treatment of ulcerative colitis: randomized, placebo-controlled pilot study. World J Gastroenterol 2008;14:2851-2857
29. + lymphocyte-associated Th2-type immune response in the intestine. J Immunol 2000;164: 6303-6312
30. Salcedo R, Ponce ML, Young HA, et al. Human endothelial cells express CCR2 and respond to MCP-1: direct role of MCP-1 in angiogenesis and tumor progression. Blood 2000;96:34-40. (Pubitemid 30456447)
31. Carulli MT, Ong VH, Ponticos M, et al. Chemokine receptor CCR2 expression bysy stemic sclerosis fibroblasts: evidence for autocrine regulation of myofibroblast differentiation. Arthritis Rheum 2005;52:3772-3782 (Pubitemid 41798215)
32. Klopp AH, Spaeth EL, Dembinski JL, et al. Tumor irradiation increases the recruitment of circulating mesenchymal stem cells into the tumor microenvironment. Cancer Res 2007;67:11687-11695
33. Lu Y, Cai Z, Galson DL, et al. Monocyte chemotactic protein-1 (MCP-1) acts as a paracrine and autocrine factor for prostate cancer growth and invasion. Prostate 2006;66:1311-1318 (Pubitemid 44384308)
34. Spring H, Schuler T, Arnold B, Hammerling G, Ganss R. Chemokines direct endothelial progenitors into tumor neovessels. Proc Natl Acad Sci U S A 2005; 102:18111-18116 (Pubitemid 41798510)
35. Moore BB, Kolodsick JE, Thannickal VJ, et al. CCR2- mediated recruitment of fibrocytes to the alveolar space after fibrotic injury. Am J Pathol 2005;166:675-684
36. Tokuyama H, Ueha S, Kurachi M, et al. The simultaneous blockade of chemokine receptors CCR2, CCR5 and CXCR3 bya non-peptide chemokine receptor antagonist protects mice from dextran sodium sulfate-mediated colitis. Int Immunol 2005;17:1023-1034
37. Sica A, Allavena P, Mantovani A. Cancer related inflammation: the macrophage connection. Cancer Lett 2008;264:204-215
38. Graves DT, Jiang YL, Williamson MJ, Valente AJ. Identification of monocyte chemotactic activity produced bymalign ant cells. Science 1989;245:1490-1493
39. Loberg RD, Ying C, Craig M, et al. Targeting CCL2 with systemic delivery of neutralizing antibodies induces prostate cancer regression in vivo . Cancer Res 2007;67:9417-9424 (Pubitemid 47535932)
40. Gong JH, Clark-Lewis I. Antagonists of monocyte chemoattractant protein 1 identified bymodification of functionallycritical NH2-terminal residues. J Exp Med 1995;181:631-640
41. Kitamoto S, Egashira K. Anti-monocyte chemoattractant protein-1 gene therapyf or cardiovascular diseases. Expert Rev Cardiovasc Ther 2003;1:393-400.
42. Furuichi K, Wada T, Iwata Y, et al. Gene therapy expressing amino-terminal truncated monocyte chemoattractant protein-1 prevents renal ischemia-reperfusion injury. J Am Soc Nephrol 2003;14:1066-1071 (Pubitemid 36359289)
43. Kitamoto S, Egashira K. Gene therapytargeting monocyte chemoattractant protein-1 for vascular disease. J Atheroscler Thromb 2002;9:261-265
44. Wada T, Furuichi K, Sakai N, et al. Gene therapyvia blockade of monocyte chemoattractant protein-1 for renal fibrosis. J Am Soc Nephrol 2004;15:940-948 (Pubitemid 38375313)
45. Yokochi S, Hashimoto H, Ishiwata Y, et al. An antiinflammatorydrug, propagermanium, may target GPIanchored proteins associated with an MCP-1 receptor, CCR2. J Interferon Cytokine Res 2001;21:389-398 (Pubitemid 32692460)
46. Iniguez MA, Rodriguez A, Volpert OV, Fresno M, Redondo JM. Cyclooxygenase-2: a therapeutic target in angiogenesis. Trends Mol Med 2003;9:73-78
47. s-axin-β-catenin signaling aixs. Science 2005;310:1504-1510
48. Shao J, Jung C, Liu C, Sheng H. Prostaglandin E2 stimulates the β-catenin/T cell factor-dependent transcription in colon cancer. J Biol Chem 2005;280: 26565-26572 (Pubitemid 41022254)
49. Arias-Negrete S, Keller K, Chadee K. Proinflammatory cytokines regulate cyclooxygenase-2 mRNA expression in human macrophages. Biochem Biophys Res Commun 1995;208:582-589
50. Tanaka S, Tatsuguchi A, Futagami S, et al. Monocyte chemoattractant protein 1 and macrophage cyclooxygenase 2 expression in colonic adenoma. Gut 2006;55: 54-61. (Pubitemid 41820636)
51. Rutgeerts P, Sandborn WJ, Feagan BG, et al. Infliximab for induction and maintenance therapyfor ulcerative colitis. N Engl J Med 2005;353:2462-2476 (Pubitemid 41770166)